These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 23159388)
1. Overexpression of p-4ebp1 in Chinese gastric cancer patients and its correlation with prognosis. Jiao X; Pan J; Qian J; Luo T; Wang Z; Yu G; Wang J Hepatogastroenterology; 2013 Jun; 60(124):921-6. PubMed ID: 23159388 [TBL] [Abstract][Full Text] [Related]
2. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma. Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer. Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069 [TBL] [Abstract][Full Text] [Related]
6. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection. Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer. Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721 [TBL] [Abstract][Full Text] [Related]
11. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis]. Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma. Hu X; Xin Y; Xiao Y; Zhao J Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316 [TBL] [Abstract][Full Text] [Related]
13. [Expression of HER-2 and leptin in gastric cancer and their clinical significance]. Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909 [TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
15. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215 [TBL] [Abstract][Full Text] [Related]
16. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. Asioli S; Maletta F; Verdun di Cantogno L; Satolli MA; Schena M; Pecchioni C; Botta C; Chiusa L; Molinaro L; Conti L; Viale G; Ingravallo G; Maiorano E; Sapino A Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays. Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783 [TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052 [TBL] [Abstract][Full Text] [Related]
19. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome. Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676 [TBL] [Abstract][Full Text] [Related]